Correlation Between Regen BioPharma and Sonnet Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Regen BioPharma and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regen BioPharma and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regen BioPharma and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Regen BioPharma and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regen BioPharma with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regen BioPharma and Sonnet Biotherapeutics.

Diversification Opportunities for Regen BioPharma and Sonnet Biotherapeutics

0.76

Correlation Coefficient

Regen BioPharma  Sonnet Biotherapeutics

Poor diversification

The 3 months correlation between Regen and Sonnet is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Regen BioPharma and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Regen BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regen BioPharma are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Regen BioPharma i.e., Regen BioPharma and Sonnet Biotherapeutics go up and down completely randomly.

Pair Corralation between Regen BioPharma and Sonnet Biotherapeutics

Assuming the 90 days horizon Regen BioPharma is expected to generate 4.75 times more return on investment than Sonnet Biotherapeutics. However, Regen BioPharma is 4.75 times more volatile than Sonnet Biotherapeutics Holdings. It trades about 0.11 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.22 per unit of risk. If you would invest  24.00  in Regen BioPharma on October 10, 2024 and sell it today you would lose (15.01) from holding Regen BioPharma or give up 62.54% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.41%
Values	Daily Returns

Regen BioPharma  vs.  Sonnet Biotherapeutics Holding

Regen BioPharma

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.

Sonnet Biotherapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sonnet Biotherapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Regen BioPharma and Sonnet Biotherapeutics

The main advantage of trading using opposite Regen BioPharma and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regen BioPharma position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.

The idea behind Regen BioPharma and Sonnet Biotherapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.